Influenza Vaccines Global Market Opportunities And Strategies To 2033

Influenza Vaccines Market 2025 – By Vaccine (Inactivated, Live Attenuated, Recombinant), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels), By Age Group (Pediatric, Adult), And By Region, Opportunities And Strategies – Global Forecast To 2034

Name: Influenza Vaccines Global Market Opportunities And Strategies To 2033
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Influenza Vaccines Global Market Opportunities And Strategies To 2033

Report Price : $4490.00 | Pages : 291 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Influenza Vaccines Market Definition

Influenza vaccines are biological preparations designed to provide immunity against the influenza virus, commonly known as the flu. These vaccines are primarily utilized by individuals across various age groups, including children, adults and the elderly, to prevent seasonal influenza infections.

The influenza vaccines market consists of sales, by entities (organizations, sole traders or partnerships), of vaccines designed to protect against the seasonal influenza virus. These vaccines work by stimulating the immune system to produce antibodies that can recognize and fight off the virus. They are designed to protect against the most prevalent strains of the virus, which are updated annually based on predictions of circulating flu strains, making them a critical tool in preventing seasonal outbreaks and reducing the severity of symptoms in those who contract the virus.

Book your 30 minutes free consultation with our research experts

Influenza Vaccines Market Size

The global influenza vaccines market reached a value of nearly $7,936.67 million in 2023, having grown at a compound annual growth rate (CAGR) of 6.30% since 2018. The market is expected to grow from $7,936.67 million in 2023 to $11,413.98 million in 2028 at a rate of 7.54%. The market is then expected to grow at a CAGR of 8.11% from 2028 and reach $16,859.78 million in 2033.

Growth in the historic period resulted from the increasing healthcare expenditure, expansion of vaccination programs, expansion of healthcare infrastructure and rise in disposable income. Factors that negatively affected growth in the historic period were high cost of vaccine.

Going forward, the increasing geriatric population, favorable governments initiatives, rising incidence of respiratory diseases and strong economic growth in emerging markets will drive the growth. Factor that could hinder the growth of the influenza vaccines market in the future include public perception and vaccine hesitancy.

Influenza Vaccines Market Drivers

The key drivers of the influenza vaccines market include:

Increasing Geriatric Population

Increasing geriatric population will drive the growth of the influenza vaccine market during this historic period. Growing geriatric population refers to the increasing number and proportion of older adults, typically defined as individuals aged 65 and older, within a population. The growing geriatric population is primarily due to advancements in healthcare, improved living conditions and declining fertility rates, leading to longer life expectancies and an aging global population. The growing geriatric population increases the demand for influenza vaccines, as older adults are more vulnerable to severe flu-related complications, making vaccination crucial for their health. For instance, in January 2024, according to a report published by the Population Reference Bureau, a US-based nonprofit organization, the population of Americans aged 65 and older is projected to increase by 47%, from 58 million in 2022 to 82 million by 2050, raising their share of the total population from 17% to 23%. Therefore, an increasing growing geriatric population will contribute to the growth of the influenza vaccine market.

Influenza Vaccines Market Restraints

The key restraints on the influenza vaccines market include:

Public Perception And Vaccine Hesitancy

Public perception and vaccine hesitancy is anticipated to significantly hinder the growth of the influenza vaccine market going forward. Vaccine hesitancy, driven by misinformation and distrust in healthcare systems, could lead to lower vaccination rates, which are crucial for controlling influenza outbreaks. For instance, Centers for Disease Control and Prevention (CDC), a US-based public health agency, estimates that 3 to 5 million severe cases of influenza occur globally each year, highlighting the critical need for widespread vaccination. Moreover, as public confidence continues to fluctuate, it is likely that many individuals will remain reluctant to receive flu vaccines, ultimately limiting market expansion and undermining efforts to enhance immunization coverage.

Influenza Vaccines Market Trends

Major trends shaping the influenza vaccines market include:

Technological Advancement To Drive Innovation In The Influenza Vaccine

Major companies in the influenza vaccine market are leveraging technological advancements, such as the development of advanced Quadrivalent Influenza vaccines, to gain a competitive edge. These vaccines are designed to protect against four different influenza virus strains. For example, in March 2024, Cadila Pharmaceuticals Limited, an Indian pharmaceutical company, launched the Cadiflu Tetra Vaccine. This innovative product aims to significantly reduce the incidence of influenza, lessen the severity of the illness and curb the transmission of the virus. The Cadiflu Tetra Vaccine offers unique features, including quadrivalent protection, an enhanced immune response through its advanced formulation and a focus on improving community health by reducing virus transmission.

Expansion Of Influenza Vaccine Production Capacity

Major companies operating in the influenza vaccine market are focusing on expansion of influenza vaccine production facilities, marking a significant advancement in their capacity to produce vaccines. An influenza vaccine production facility refers to a recently established or planned facility designed to manufacture vaccines targeting influenza viruses. For instance, in April 2023, Sinovac Biotech Ltd., a China-based biotechnology company, launched a new influenza vaccine production facility to meet the growing demand for vaccines, particularly in light of seasonal flu outbreaks and potential pandemics. The new facility will focus on the production of quadrivalent influenza vaccines, which provide protection against four different strains of the influenza virus, thereby improving overall vaccination efficacy. SINOVAC aims to ensure high-quality production that adheres to international safety standards. This initiative not only strengthens SINOVAC's position in the global vaccine market but also contributes to broader public health efforts by ensuring a reliable supply of effective influenza vaccines.

Opportunities And Recommendations In The Influenza Vaccines Market

Opportunities – The top opportunities in the automotive seat belts market segmented by seat belt type will arise in the three-point segment, which will gain $3,436.0 million of global annual sales by 2028. The top opportunities in the automotive seat belts market segmented by technology will arise in the pretensioner automotive seatbelts segment, which will gain $1,505.4 million of global annual sales by 2028. The top opportunities in the automotive seat belts market segmented by sales channel will arise in the original equipment manufacturer (OEM) segment, which will gain $3,039.8 million of global annual sales by 2028. The top opportunities in the automotive seat belts market segmented by vehicles will arise in the passenger cars segment, which will gain $2,492.8 million of global annual sales by 2028. The automotive seat belts market size will gain the most in China at $984.7 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the influenza vaccines companies to focus on advanced quadrivalent vaccines to enhance market position, focus on expanding vaccine production capacity, focus on MRNA influenza vaccine development, focus on recombinant vaccines, focus on quadrivalent vaccines, focus on nasal spray segment, focus on adult market, expand in emerging markets, focus on expanding strategic partnerships, focus on pricing strategies to enhance market position, focus on digital marketing channels, focus on collaborating with healthcare professionals and focus on hospitals and pharmacies.

Influenza Vaccines Market Segmentation

The influenza vaccines market is segmented by vaccine type, by valency, by route of administration, by age group and by distribution channel.

By Vaccine Type –
The influenza vaccines market is segmented by vaccine type into:

a) Inactivated
b) Live Attenuated
c) Recombinant

The inactivated market was the largest segment of the influenza vaccines market segmented by vaccine type, accounting for 88.44% or $7,019.11 million of the total in 2023. Going forward, the recombinant segment is expected to be the fastest growing segment in the influenza vaccines market segmented by vaccine type, at a CAGR of 7.67% during 2023-2028.

By Valency –
The influenza vaccines market is segmented by valency into:

a) Quadrivalent
b) Trivalent

The quadrivalent market was the largest segment of the influenza vaccines market segmented by valency, accounting for 77.04% or $6,114.41 million of the total in 2023. Going forward, the quadrivalent segment is expected to be the fastest growing segment in the influenza vaccines market segmented by valency, at a CAGR of 7.83% during 2023-2028.

By Route Of Administration –
The influenza vaccines market is segmented by route of administration into:

a) Injection
b) Nasal Spray

The injection market was the largest segment of the influenza vaccines market segmented by route of administration, accounting for 93.02% or $7,382.57 million of the total in 2023. Going forward, the nasal spray segment is expected to be the fastest growing segment in the influenza vaccines market segmented by route of administration, at a CAGR of 7.63% during 2023-2028.

By Age Group –
The influenza vaccines market is segmented by age group into:

a) Pediatric
b) Adult

The adult market was the largest segment of the influenza vaccines market segmented by age group, accounting for 65.85% or $5,226.36 million of the total in 2023. Going forward, the adult segment is expected to be the fastest growing segment in the influenza vaccines market segmented by age group, at a CAGR of 8.34% during 2023-2028.

By Distribution Channel –
The influenza vaccines market is segmented by distribution channel into:

a) Hospitals And Pharmacies
b) Government And Institutional Supply
c) Other Distribution Channels

The hospitals and pharmacies market was the largest segment of the influenza vaccines market segmented by distribution channel, accounting for 57.94% or $4,598.46 million of the total in 2023. Going forward, the government and institutional supply segment is expected to be the fastest growing segment in the influenza vaccines market segmented by distribution channel, at a CAGR of 8.21% during 2023-2028.

By Geography - The influenza vaccines market is segmented by geography into:

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA
• Canada

• Brazil

• France
• Germany
• UK
• Italy
• Spain

• Russia

North America was the largest region in the influenza vaccines market, accounting for 41.42% or $3,287.45 million of the total in 2023. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the influenza vaccines market will be Asia Pacific and South America where growth will be at CAGRs of 9.04% and 8.77% respectively. These will be followed by Middle East and Africa where the markets are expected to grow at CAGRs of 8.56% and 8.09% respectively.

Influenza Vaccines Market Competitive Landscape

Major Competitors are:

Sanofi SA

Seqirus (CSL Limited)

GlaxoSmithKline Plc

Daiichi Sankyo Co Ltd

Pfizer Inc

Other Competitors Include:

Abbott Laboratories

AstraZeneca PLC

Sinovac Biotech Ltd

Serum Institute of India Pvt Ltd

BioDiem Ltd

China National Pharmaceutical Group Corporation (Sinopharm)

Shanghai Fosun Pharmaceutical Group Co Ltd

Sinovac Biotech Co Ltd

Clover Biopharmaceuticals Ltd

Cadila Pharmaceuticals

GlaxoSmithKline (GSK)

CureVac

Novartis AG

Biomed-Lublin

Polpharma

Vaccinuri Suceava

Microgen

R-Pharm

Vaxess Technologies

Merck & Co Inc

Viatris Inc

Emergent BioSolutions Inc

Altimmune Inc

Baxter International Inc

Moderna Inc

Novavax Inc

Johnson & Johnson

Dynavax Technologies Corporation

Instituto Butantan

Biofarma Argentina

Laboratorio Pfeiffer

Laboratório São Paulo

Sinergium Biotech

SK Bioscience Co

Kemin Industries Inc

ilender Corporation

Abu Dhabi Health Services Company PJSC

BioMedical Ltd

MediWound Ltd

Koçak Farma

Abdi Ibrahim

GC Biopharma

1 Executive Summary

1.1 Influenza Vaccines – Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition

6.2 Summary

6.3 Influenza Vaccines Market Definition And Segmentations

6.4 Market Segmentation By Vaccine Type

6.4.1 Inactivated

6.4.2 Live Attenuated

6.4.3 Recombinant

6.5 Market Segmentation By Valency

6.5.1 Quadrivalent

6.5.2 Trivalent

6.6 Market Segmentation By Route Of Administration

6.6.1 Injection

6.6.2 Nasal Spray

6.7 Market Segmentation By Age Group

6.7.1 Pediatric

6.7.2 Adult

6.8 Market Segmentation By Distribution Channel

6.8.1 Hospitals And Pharmacies

6.8.2 Government And Institutional Supply

6.8.3 Other Distribution Channels

7 Major Market Trends

7.1 Technological Advancement To Drive Innovation In The Influenza Vaccine

7.2 Expansion Of Influenza Vaccine Production Capacity

7.3 Advancements In Influenza Vaccine Development

7.4 Strategic Partnerships And Collaborations Among Market Players

8 Influenza Vaccines Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Influenza Vaccines Market

8.2 Impact Of The War In Ukraine On The Influenza Vaccines Market

8.3 Impact Of High Inflation On The Influenza Vaccines Market

9 Global Market Size and Growth

9.1 Market Size

9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

9.2.1 Market Drivers 2018 – 2023

9.2.2 Market Restraints 2018 – 2023

9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

9.3.1 Market Drivers 2023 – 2028

9.3.2 Market Restraints 2023 – 2028

10 Global Influenza Vaccines Market Segmentation

10.1 Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.2 Global Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.3 Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.4 Global Influenza Vaccines Market, Segmentation By Age Group, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.5 Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

11 Influenza Vaccines Market, Regional and Country Analysis

11.1 Global Influenza Vaccines Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

11.2 Global Influenza Vaccines Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary

12.1.1 Market Overview

12.1.2 Region Information

12.1.3 Market Information

12.1.4 Background Information

12.1.5 Government Initiatives

12.1.6 Regulations

12.1.7 Regulatory Bodies

12.1.8 Major Associations

12.1.9 Taxes Levied

12.1.10 Corporate Tax Structure

12.1.11 Investments

12.1.12 Major Companies

12.2 Asia Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.3 Asia Pacific Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.4 Asia Pacific Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.5 Asia-Pacific Influenza Vaccines Market: Country Analysis

12.6 China Market

12.7 Summary

12.7.1 Market Overview

12.7.2 Country Information

12.7.3 Market Information

12.7.4 Background Information

12.7.5 Government Initiatives

12.7.6 Regulations

12.7.7 Regulatory Bodies

12.7.8 Major Associations

12.7.9 Taxes Levied

12.7.10 Corporate Tax Structure

12.7.11 Investments

12.7.12 Major Companies

12.8 China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.9 China Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.10 China Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.11 India Market

12.12 India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.13 India Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.14 India Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.15 Japan Market

12.16 Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.17 Japan Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.18 Japan Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.19 Australia Market

12.20 Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.21 Australia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.22 Australia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.23 Indonesia Market

12.24 Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.25 Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.26 Indonesia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.27 South Korea Market

12.28 South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.29 South Korea Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.30 South Korea Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary

13.1.1 Market Overview

13.1.2 Region Information

13.1.3 Market Information

13.1.4 Background Information

13.1.5 Government Initiatives

13.1.6 Regulations

13.1.7 Regulatory Bodies

13.1.8 Major Associations

13.1.9 Taxes Levied

13.1.10 Corporate tax structure

13.1.11 Investments

13.1.12 Major Companies

13.2 Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.3 Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.4 Western Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.5 Western Europe Influenza Vaccines Market: Country Analysis

13.6 UK Market

13.7 UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.8 UK Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.9 UK Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.10 Germany Market

13.11 Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.12 Germany Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.13 Germany Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.14 France Market

13.15 France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.16 France Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.17 France Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.18 Italy Market

13.19 Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.20 Italy Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.21 Italy Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.22 Spain Market

13.23 Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.24 Spain Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.25 Spain Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary

14.1.1 Market Overview

14.1.2 Region Information

14.1.3 Market Information

14.1.4 Background Information

14.1.5 Government Initiatives

14.1.6 Regulations

14.1.7 Regulatory Bodies

14.1.8 Major Associations

14.1.9 Taxes Levied

14.1.10 Corporate Tax Structure

14.1.11 Major companies

14.2 Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.3 Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.4 Eastern Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.5 Eastern Europe Influenza Vaccines Market: Country Analysis

14.6 Russia Market

14.7 Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.8 Russia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.9 Russia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary

15.1.1 Market Overview

15.1.2 Region Information

15.1.3 Market Information

15.1.4 Background Information

15.1.5 Government Initiatives

15.1.6 Regulations

15.1.7 Regulatory Bodies

15.1.8 Major Associations

15.1.9 Taxes Levied

15.1.10 Corporate Tax Structure

15.1.11 Investments

15.1.12 Major Companies

15.2 North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.3 North America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.4 North America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.5 North America Influenza Vaccines Market: Country Analysis

15.6 USA Market

15.7 Summary

15.7.1 Market Overview

15.7.2 Country Information

15.7.3 Market Information

15.7.4 Background Information

15.7.5 Government Initiatives

15.7.6 Regulations

15.7.7 Regulatory Bodies

15.7.8 Major Associations

15.7.9 Taxes Levied

15.7.10 Corporate Tax Structure

15.7.11 Investments

15.7.12 Major Companies

15.8 USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.9 USA Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.10 USA Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.11 Canada Market

15.12 Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.13 Canada Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.14 Canada Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary

16.1.1 Market Overview

16.1.2 Region Information

16.1.3 Market Information

16.1.4 Background Information

16.1.5 Government Initiatives

16.1.6 Regulations

16.1.7 Regulatory Bodies

16.1.8 Major Associations

16.1.9 Taxes Levied

16.1.10 Corporate Tax Structure

16.1.11 Investments

16.1.12 Major Companies

16.2 South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.3 South America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.4 South America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.5 South America Influenza Vaccines Market: Country Analysis

16.6 Brazil Market

16.7 Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.8 Brazil Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.9 Brazil Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary

17.1.1 Market Overview

17.1.2 Region Information

17.1.3 Market Information

17.1.4 Background Information

17.1.5 Government Initiatives

17.1.6 Regulations

17.1.7 Regulatory Bodies

17.1.8 Major Associations

17.1.9 Taxes Levied

17.1.10 Corporate Tax Structure

17.1.11 Major Companies

17.2 Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17.3 Middle East Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17.4 Middle East Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary

18.2.1 Market Overview

18.2.2 Region Information

18.2.3 Market Information

18.2.4 Background Information

18.2.5 Government Initiatives

18.2.6 Regulations

18.2.7 Regulatory Bodies

18.2.8 Major Associations

18.2.9 Taxes Levied

18.2.10 Corporate Tax Structure

18.2.11 Investments

18.2.12 Major Companies

18.3 Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18.4 Africa Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18.5 Africa Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles

19.2 Sanofi S.A.

19.2.1 Company Overview

19.2.2 Products And Services

19.2.3 Business Strategy

19.2.4 Financial Overview

19.3 Seqirus (CSL Limited)

19.3.1 Company Overview

19.3.2 Products And Services

19.3.3 Business Strategy

19.3.4 Financial Overview

19.4 GlaxoSmithKline plc

19.4.1 Company Overview

19.4.2 Products And Services

19.4.3 Business Strategy

19.4.4 Financial Overview

19.5 Daiichi Sankyo Co. Ltd

19.5.1 Company Overview

19.5.2 Products And Services

19.5.3 Business Strategy

19.5.4 Financial Overview

19.6 Pfizer Inc

19.6.1 Company Overview

19.6.2 Products And Services

19.6.3 Business Strategy

19.6.4 Financial Overview

20 Other Major And Innovative Companies

20.1 Abbott Laboratories

20.1.1 Company Overview

20.1.2 Products and Services

20.2 AstraZeneca Plc

20.2.1 Company Overview

20.2.2 Products And Services

20.3 Sinovac Biotech Ltd

20.3.1 Company Overview

20.3.2 Products And Services

20.4 Serum Institute of India

20.4.1 Company Overview

20.4.2 Products And Services

20.5 BioDiem Ltd

20.5.1 Company Overview

20.5.2 Products and Services

20.6 Takeda Pharmaceutical Company Limited

20.6.1 Company Overview

20.6.2 Products and Services

20.7 EMERGENT BIOSOLUTIONS INC

20.7.1 Company Overview

20.7.2 Products and Services

20.8 BiondVax Pharmaceuticals Ltd

20.8.1 Company Overview

20.8.2 Products and Services

20.9 Gamma Vaccines Pty Ltd

20.9.1 Company Overview

20.9.2 Products and Services

20.10 Osivax

20.10.1 Company Overview

20.10.2 Products and Services

20.11 Vaxart Inc

20.11.1 Company Overview

20.11.2 Products and Services

20.12 Vaxess Technologies Inc

20.12.1 Company Overview

20.12.2 Products and Services

20.13 Biken Techno Corp

20.13.1 Company Overview

20.13.2 Products and Services

20.14 Johnson & Johnson

20.14.1 Company Overview

20.14.2 Products and Services

20.15 Flugen Inc

20.15.1 Company Overview

20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 GSK Acquired CureVac

23.2 AstraZeneca Acquired Icosavax

23.3 GSK Acquired Affinivax

24 Opportunities And Strategies

24.1 Global Influenza Vaccines Market In 2028 – Countries Offering Most New Opportunities

24.2 Global Influenza Vaccines Market In 2028 – Segments Offering Most New Opportunities

24.3 Global Influenza Vaccines Market In 2028 – Growth Strategies

24.3.1 Market Trend Based Strategies

24.3.2 Competitor Strategies

25 Influenza Vaccines Market, Conclusions And Recommendations

25.1 Conclusions

25.2 Recommendations

25.2.1 Product

25.2.2 Place

25.2.3 Price

25.2.4 Promotion

25.2.5 People

26 Appendix

26.1 Geographies Covered

26.2 Market Data Sources

26.3 Research Methodology

26.4 Currencies

26.5 The Business Research Company

26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global Influenza Vaccines Market, Historic, 2018 – 2023, $ Million

Table 2: Global Influenza Vaccines Market, Forecast, 2023 – 2028, 2033F, $ Million

Table 3: Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 4: Global Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 5: Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 6: Global Influenza Vaccines Market, Segmentation By Age Group, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 7: Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 8: Global Influenza Vaccines Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 9: Global Influenza Vaccines Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 10: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $

Table 11: Asia-Pacific Population, By Country, 2018-2028, Millions

Table 12: Asia Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 13: Asia Pacific Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 14: Asia Pacific Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 15: China GDP Per Capita, 2018-2023, $

Table 16: China Population, 2018-2028, Millions

Table 17: China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 18: China Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 19: China Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 20: India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 21: India Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 22: India Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 23: Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 24: Japan Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 25: Japan Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 26: Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 27: Australia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 28: Australia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 29: Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 30: Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 31: Indonesia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 32: South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 33: South Korea Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 34: South Korea Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 35: Western Europe GDP Per Capita, By Country, 2018-2023, $

Table 36: Western Europe Population, By Country, 2018-2028, Millions

Table 37: Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 38: Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 39: Western Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 40: UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 41: UK Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 42: UK Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 43: Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 44: Germany Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 45: Germany Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 46: France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 47: France Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 48: France Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 49: Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 50: Italy Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 51: Italy Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 52: Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 53: Spain Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 54: Spain Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 55: Eastern Europe GDP Per Capita, By Country, 2018-2023, $

Table 56: Eastern Europe Population, By Country, 2018-2028, Millions

Table 57: Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 58: Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 59: Eastern Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 60: Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 61: Russia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 62: Russia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 63: North America GDP Per Capita, By Country, 2018-2023, $

Table 64: North America Population, By Country, 2018-2028, Millions

Table 65: North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 66: North America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 67: North America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 68: USA GDP Per Capita, 2018-2023, $

Table 69: USA Population, 2018-2028, Millions

Table 70: USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 71: USA Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 72: USA Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 73: Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 74: Canada Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 75: Canada Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 76: South America GDP Per Capita, By Country, 2018-2023, $

Table 77: South America Population, By Country, 2018-2028, Millions

Table 78: South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 79: South America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 80: South America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 81: Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 82: Brazil Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 83: Brazil Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 84: Middle East GDP Per Capita, By Country, 2018-2023, $

Table 85: Middle East Population, By Country, 2018-2028, Millions

Table 86: Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 87: Middle East Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 88: Middle East Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 89: Africa GDP Per Capita, By Country, 2018-2023, $

Table 90: Africa Population, By Country, 2018-2028, Millions

Table 91: Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 92: Africa Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 93: Africa Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 94: Global Influenza Vaccines Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)

Table 95: Sanofi S.A. – Financial Overview, 2019 – 2023, $Billion

Table 96: Seqirus (CSL Limited) – Financial Overview, 2019 – 2023, $Billion

Table 97: GlaxoSmithKline plc – Financial Overview, 2019 – 2023, $ Billion

Table 98: Daiichi Sankyo Co. Ltd – Financial Overview, 2019 – 2023, $Billion

Table 99: Pfizer Inc – Financial Overview, 2019 – 2023, $Billion

Table 100: Influenza Vaccines Market, Competitive Benchmarking (In USD Millions)

Table 101: Influenza Vaccines Market, Competitive Dashboard

Table 102: Global Influenza Vaccines Market Size Gain ($ Million), 2023 – 2028, By Country

Table 103: Global Influenza Vaccines Market Size Gain ($ Million), Segmentation By Vaccine Type, 2023 – 2028

Table 104: Global Influenza Vaccines Market Size Gain ($ Million), Segmentation By Valency, 2023 – 2028

Table 105: Global Influenza Vaccines Market Size Gain ($ Million), Segmentation By Route Of Administration, 2023 – 2028

Table 106: Global Influenza Vaccines Market Size Gain ($ Million), Segmentation By Age Group, 2023 – 2028

Table 107: Global Influenza Vaccines Market Size Gain ($ Million), Segmentation By Distribution Channel, 2023 – 2028

Table 108: Influenza Vaccines Market Data Sources

List Of Figures

Figure 1: Global Influenza Vaccines Market Segmentation By Vaccine Type

Figure 2: Global Influenza Vaccines Market Segmentation By Valency

Figure 3: Global Influenza Vaccines Market Segmentation By Route Of Administration

Figure 4: Global Influenza Vaccines Market Segmentation By Age Group

Figure 5: Global Influenza Vaccines Market Segmentation By Distribution Channel

Figure 6: Global Influenza Vaccines Market, Historic, 2018 – 2023, $ Million

Figure 7: Global Influenza Vaccines Market, Forecast, 2023 – 2028, 2033F, $ Million

Figure 8: Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 9: Global Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 10: Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 11: Global Influenza Vaccines Market, Segmentation By Age Group, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 12: Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 13: Global Influenza Vaccines Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 14: Global Influenza Vaccines Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 15: Asia Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 16: Asia Pacific Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 17: Asia Pacific Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 18: China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 19: China Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 20: China Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 21: India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 22: India Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 23: India Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 24: Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 25: Japan Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 26: Japan Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 27: Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 28: Australia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 29: Australia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 30: Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 31: Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 32: Indonesia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 33: South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 34: South Korea Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 35: South Korea Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 36: Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 37: Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 38: Western Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 39: UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 40: UK Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 41: UK Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 42: Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 43: Germany Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 44: Germany Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 45: France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 46: France Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 47: France Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 48: Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 49: Italy Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 50: Italy Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 51: Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 52: Spain Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 53: Spain Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 54: Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 55: Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 56: Eastern Europe Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 57: Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 58: Russia Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 59: Russia Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 60: North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 61: North America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 62: North America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 63: USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 64: USA Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 65: USA Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 66: Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 67: Canada Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 68: Canada Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 69: South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 70: South America Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 71: South America Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 72: Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 73: Brazil Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 74: Brazil Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 75: Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 76: Middle East Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 77: Middle East Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 78: Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 79: Africa Influenza Vaccines Market, Segmentation By Valency, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 80: Africa Influenza Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 81: Global Influenza Vaccines Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)

Figure 82: Sanofi S.A. – Financial Overview, 2019 – 2023, $ Billion

Figure 83: Seqirus (CSL Limited) – Financial Overview, 2019 – 2023, $ Billion

Figure 84: GlaxoSmithKline plc – Financial Overview, 2019 – 2023, $ Billion

Figure 85: Daiichi Sankyo Co. Ltd – Financial Overview, 2019 – 2023, $ Billion

Figure 86: Pfizer Inc – Financial Overview, 2019 – 2023, $ Billion

Figure 87: Geographic Regions Covered

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine, Therapeutic Nutrients And Mineralsa) Cardiovascular Drugs Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti-Thrombotic, Angina Pectoris, Congestive Heart Failure, Other Cardiovascular Drugsb) Dermatology Drugs Type (Acne Drugs, Dermatitis Drugs, Psoriasis Drugs, Other Drugs For Dermatology Diseasesc) Gastrointestinal Drugs Type (Antacids, Antiulcerants, Antiemetics And Antinauseants, Antidiarrhealsd) Genito-Urinary Drugs Type (Hormonal Contraceptives, Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Influenza Vaccines Global Market Opportunities And Strategies To 2033

Influenza Vaccines Global Market Opportunities And Strategies To 2033

Influenza Vaccines Market Definition

Influenza Vaccines Market Size

Influenza Vaccines Market Drivers

Influenza Vaccines Market Restraints

Influenza Vaccines Market Trends

Opportunities And Recommendations In The Influenza Vaccines Market

Influenza Vaccines Market Segmentation

Influenza Vaccines Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

Frequently Asked Questions